OWP
FBRX icon

Old Well Partners’s Forte Biosciences FBRX Stock Holding History

Old Well Partners’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,744
Closed -$71.3K – 37
2023
Q2 		$71.3K Hold
2,744
– – 0.06% 32
2023
Q1 		$69.3K Hold
2,744
– – 0.05% 31
2022
Q4 		$68.6K Hold
2,744
– – 0.06% 31
2022
Q3 		$73K Buy
+2,744
New +$87.2K 0.06% 37

Other funds holding FBRX

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Old Well Partners's FBRX Position: Q3 2023 in Review

Old Well Partners sold out of Forte Biosciences (FBRX) in Q3 2023, closing a stake of 2,744 shares — an estimated $71.3K sold.

Old Well Partners first reported a position in FBRX in Q3 2022 and held it in 4 quarters. The position peaked at $73K in Q3 2022. 30 funds tracked by Wall St. Rank hold FBRX as of Q3 2023.

  • Old Well Partners reported no remaining Forte Biosciences position as of Q3 2023 after selling out during the quarter.
  • Old Well Partners sold 2,744 Forte Biosciences shares in Q3 2023, an estimated $71.3K.
  • Old Well Partners first reported a position in Forte Biosciences in Q3 2022 and held it in 4 quarters.
  • Old Well Partners's Forte Biosciences position peaked at $73K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2023.

Based on Old Well Partners's 13F filing for Q3 2023, filed 14 Nov 2023.